Budesonide
NDC Package 0904-7166-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Budesonide is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. Marketed by Major Pharmaceuticals, this product is identified by NDC 0904-7166 and is authorized under FDA application ANDA206200.

Identification & Billing

NDC Package Code
0904-7166-10
Package Description
20 BLISTER PACK in 1 CARTON / 1 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK
Product Code
0904-7166
11-Digit Billing Format
00904716610

Clinical Specifications

Proprietary Name
Budesonide
Dosage Form
-
Usage Information
Budesonide is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. This medication belongs to a class of drugs known as corticosteroids. It works directly in the lungs to make breathing easier by reducing the irritation and swelling of the airways. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed.

Regulatory & Marketing

Labeler Name
Major Pharmaceuticals
FDA Application #
ANDA206200
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-15-2017
End Marketing Date
09-15-2017
Listing Expiration
09-15-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0904-7166-10 identifies a specific commercial package of 20 blister pack in 1 carton / 1 capsule, delayed release in 1 blister pack of Budesonide, labeled by Major Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Major Pharmaceuticals on September 15, 2017. The current certification is valid through September 15, 2017.

What are the primary indications for this medication?

Budesonide is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. This medication belongs to a class of drugs known as corticosteroids. It works directly in the lungs to make breathing easier by reducing the irritation and swelling of the airways. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed.

How is this Major Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00904716610. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0904-7166-10
11-Digit CMS (5-4-2)
00904-7166-10

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.